Company Overview and News

0
Ashok Leyland, ICICI Lombard results

19m thehindubusinessline
Nearly two dozen companies, including 8K Miles Software Services, Ashok Leyland, Atishay, Crisil, Federal Bank, Goa Carbon, Hindustan Media Ventures, ICICI Lombard General Insurance, Integrated Capital, Jindal Stainless, Indian Metals & Ferro Alloys, Muthoot Capital Services, Nucleus Software Exports, Rallis India, Sintex Industries, Tata Sponge Iron and Zee Entertainment Enterprises will declare their April-June quarter results on Tuesday.
RALLIS GOACARBON 500469 IDBI 531209 MUTHTFN FEDA TATASPONGE FEDS 500355 JSL 500477 ZEEL FEDERALBNK 509567 ASHOKLEY 513010 500116 IBN 532508 FDBAY FERROALL AKLD 533217 511766 ICICIBANK ZEEEY 532174 SINTEX 502742 505537 500141 AKLS NUCLEUS HMVL

4
Podcast | Pick of the day - NCLT okays Tatas#39; bye bye to Cyrus Mistry

2018-07-09 moneycontrol
It appears there is finally some resolution in the eighteen-month-long battle between the Tata Sons and Cyrus Mistry at the National Company Law Tribunal (NCLT). Today, the NCLT dismissed Cyrus Mistry’s plea for his alleged illegal removal from the post of Tata Sons’ Chairman. And that is our Pick of the Day.
500408 TTML TATACOFFEE 500800 BHUSANSTL TTAZF TTQQY BHRQY TATACOMM TTNQY TATACHEM TTAEY 532301 TGBL 500470 532540 TATAINVEST TATASPONGE 501301 500570 BHARTIARTL TATAMOTORS 500770 500055 513010 TGBA TATAMETALI TATAPOWER 513434 532454 TTST TATASTEEL TATLY 532371 TPCL TATAELXSI TCS 500400 500483 TATAGLOBAL TTM

4
Tata Group stocks rally 1-5% after NCLT rules in Tata Sons#39; favour in Cyrus Mistry case

2018-07-09 moneycontrol
Tata Group stocks gained on Monday after the National Company Law Tribunal ruled in favour of Tata Sons against Cyrus Mistry's plea with regards to his removal as Tata Sons Chairman.
500408 TTML TTQQY TATACOMM TTNQY TATACHEM 500470 532540 TATAINVEST TATASPONGE 501301 500570 TATAMOTORS 500770 513010 TATAMETALI TATAPOWER 513434 TTST TATASTEEL TATLY 532371 TPCL TATAELXSI TCS 500400 500483 TTM

5
Closing Bell: Sensex rises 114 pts, Nifty ends tad below 10,700; pharma, auto, IT outshine

2018-07-03 moneycontrol
Global Update: Asian stocks closed mixed as investors remained cautious ahead of a July 6 deadline when the US is set to impose tariffs on $34 billion worth of goods from China. Beijing is then expected to respond with charges of its own on US goods, reports CNBC.
500325 UBL TTQQY 532478 TATACHEM CADILAHC 532321 BJJQY 500570 500770 RLNIY 513010 AXB MRZUY 532500 AXBA BAJAJFINSV BAJFINANCE 532670 TATASTEEL TATLY MARUTI 500180 KOTAKBANK 507458 523204 SSWL 513262 533271 RELIANCE IDBI 532737 ASHOKA 532978 RENUKA 532215 ABAN 500470 AXISBANK RIGD TATASPONGE HDFCBANK NIHARINF TATAMOTORS 500034 500116 KMBKY TATAMETALI IBN UBHOLDINGS 513434 532967 KIRIINDUS UNBWY CDLYY AXBKY ICICIBANK TTST EMKAY HDB 532174 531083 500247 TTM

0
Tata Sponge Iron Limited - Shareholders meeting

2018-06-29 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
513010 TATASPONGE

0
Tata Sponge Iron Limited - Trading Window

2018-06-25 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
513010 TATASPONGE

0
Tata Sponge Iron Limited - Dividend

2018-04-18 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
513010 TATASPONGE

0
Tata Sponge Iron Limited - AGM/Book Closure

2018-04-18 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
513010 TATASPONGE

0
Tata Sponge Iron Limited - Financial Result Updates

2018-04-18 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
513010 TATASPONGE

0
Tata Sponge Iron Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-04-17 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
513010 TATASPONGE

0
Tata Sponge Iron Limited - Outcome of Board Meeting

2018-04-17 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
513010 TATASPONGE

27
Market Live: Sensex, Nifty trade lower; all sectoral indices in red except FMCG

2018-04-17 moneycontrol
12:42 pm Market Update: The market is trading mildly lower amid consolidation, after rising in previous 8 consecutive sessions, as investors look for more corporate earnings due over next one and half months.
IOC ORCHIDPHAR 533271 ASHOKA 532712 532832 GLKQY 500470 532187 RCOM 506395 TATASPONGE HDFCBANK BJJQY 500570 500031 TATAMOTORS 500033 500034 GLENMARK 513010 INDUSINDBK FORCEMOT 530965 COROMANDEL 532843 BAJFINANCE TTST 524372 532296 TATASTEEL FORTIS TATLY HDB 500180 IBREALEST BAJAJELEC TTM

Related Articles

CYTX: Cytori Therapeutics Analysis and Research Report

9h - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CATB: Catabasis Pharmaceuticals Analysis and Research Report

2018-07-13 - Asif

Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...

WMT: Walmart Analysis and Research Report

2018-07-09 - Asif

Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...